OPEN ACCESS pISSN 2234-3806
eISSN 2234-3814

Table. 1.

Demographic, clinical, and hematological data according to the presence of CHIP mutations

Variable Overall (N=90) CHIP mutation P

No (N=53) Yes (N=37)
Age (yr) 67 (60–86) 66 (60–83) 69 (60–86) 0.093
Male (N) 59 (66) 31 (58) 28 (76) 0.116
Female (N) 31 (34) 22 (42) 9 (24) 0.116
BMI (kg/m2) 25 (18–32) 25 (20–31) 25 (18–32) 0.517
Hypertension (N) 64 (71) 38 (72) 26 (70) 1.000
Diabetes (N) 28 (31) 16 (30) 12 (32) 0.822
Dyslipidemia (N) 46 (51) 27 (51) 19 (51) 1.000
Leukocyte count ( × 109 L) 6.6 (2.8–11.7) 6.6 (2.8–9.6) 6.3 (4.1–11.7) 0.733
Absolute neutrophil count ( × 109 L) 4.0 (1.6–8.1) 4.0 (2.2–7.0) 4.0 (1.6–8.1) 0.989
Lymphocyte count ( × 109 L) 1.8 (0.7–3.4) 1.8 (0.7–3.2) 2.0 (0.9–3.4) 0.481
Hb (g/L) 139 (119–166) 139 (119–166) 138 (120–163) 0.706
Mean corpuscular volume (fL) 93.0 (81.5–102.0) 93.6 (81.5–101.2) 92.1 (83.5–102.0) 0.218
Platelet count ( × 109 L) 215 (150–375) 219 (154–375) 202 (150–347) 0.233

Values are median (range) or number (%).

Abbreviations: CHIP, clonal hematopoiesis of indeterminate potential; BMI, body mass index.

Ann Lab Med 2023;43:145~152 https://doi.org/10.3343/alm.2023.43.2.145

© Ann Lab Med